Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $366.22M.
ENTERPRISE VALUE (EV)
$366.22M
MapLight Therapeutics, Inc.
Market Cap
$412.06M
Enterprise Value (EV)
$366.22M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $412.06M | $366.22M |
| Strata Critical Medical, Inc. (SRTA)vs › | $410.03M | $397.97M |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | $517.42M |
| Myriad Genetics, Inc. (MYGN)vs › | $407.02M | $502.32M |
| Prothena Corporation plc (PRTA)vs › | $418.30M | $137.10M |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.51M | $329.38M |
| Senseonics Holdings, Inc. (SENS)vs › | $419.58M | $436.67M |
| Rezolute, Inc. (RZLT)vs › | $404.30M | $394.62M |
| YD Bio Limited Ordinary Shares (YDES)vs › | $420.03M | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $420.49M | $254.18M |
Market Cap
$412.06M
Total Debt
$891000.00
Cash
$46.73M
Enterprise Value
$366.22M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Why use EV instead of Market Cap?
